Biotest

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark Biotest was filed as Word mark on 06/26/2020 at the World Intellectual Property Organization.

Trademark Details Last update: March 24, 2022

Trademark form Word mark
File reference 1553681
Countries Ireland Israel India Oman Singapore Tunisia United States of America (USA) Albania Switzerland Spain Hungary Russia
Base trademark DE No. 30 2020 108 606, June 25, 2020
Application date June 26, 2020
Expiration date December 21, 2021

Trademark owner

Landsteinerstraße 5
63303 Dreieich
DE

Trademark representatives

goods and services

01 Chemicals used in industry and science; biological preparations for use in industry and science, namely proteins and protein preparations made from human blood, blood plasma or blood serum, in particular human albumin, coagulation factors and immunoglobulins; plasma and serum preparations; recombinant proteins; plasma fractions; excipients for the stabilization of medicines, in particular human albumin
05 Pharmaceutical preparations; medical and veterinary preparations; blood products, serum preparations; blood substitute, blood plasma substitute and plasma expanders; serum preparations; serum proteins and solutions thereof; proteins and protein preparations made from human blood, blood plasma or blood serum; human albumin, coagulation factors and coagulation inhibitors, in particular factor VII, factor VIII, factor IX, factor X, fibrinogen, von Willebrand factor; immunoglobulin preparations, immunoglobulins and hyperimmunoglobulins; recombinant proteins, in particular coagulation factors and monoclonal antibodies; pharmaceutical products for haematology, immunology, neurology, intensive medicine, transplantation medicine, oncology, for influencing blood diseases of the immune system and oncological diseases; pharmaceutical products for preventing and treating viral diseases, for treating diseases of the immune system, for treating autoimmune diseases and oncological diseases; immunosuppressant, immunomodulatory, anti-inflammatory, antiallergic, hyposensitizing and detoxifying or toxine-neutralizing medicines
44 Medical services, in particular collecting blood plasma

Trademark history

Date Document number Area Entry
February 11, 2022 2022/12 Gaz DE RAW: Total Ceasing Effect
October 13, 2021 2021/45 Gaz Correction
September 1, 2021 2021/36 Gaz CH Rejection
August 30, 2021 2021/35 Gaz RU Rejection
July 6, 2021 2021/27 Gaz ES Rejection
March 24, 2021 2021/13 Gaz IE Rejection
February 25, 2021 2021/9 Gaz SG Rejection
February 16, 2021 2021/7 Gaz ES Rejection
January 28, 2021 2021/7 Gaz HU Rejection
January 28, 2021 2021/6 Gaz IL Rejection
December 29, 2020 2020/53 Gaz RU Rejection
December 24, 2020 2021/1 Gaz SG Rejection
October 20, 2020 2020/44 Gaz IN Rejection
June 26, 2020 2020/39 Gaz DE Registration

ID: 141553681